The A-List Clinic

The A-List Clinic operates as a telehealth-focused preventative medicine practice serving patients throughout California, founded in 2022 by Czarina Enriquez, FNP. The clinic delivers hormone optimization protocols and medical weight loss programs through virtual consultations, eliminating geographic barriers for California residents seeking peptide-based metabolic interventions. Enriquez structures patient care around comprehensive lab analysis, individualized dosing protocols, and ongoing monitoring to address hormonal imbalances and metabolic dysfunction that contribute to weight gain, fatigue, and age-related decline.

The clinic's medical weight loss programs center on GLP-1 receptor agonist peptides, specifically tirzepatide and semaglutide, prescribed following thorough metabolic assessment and contraindication screening. Tirzepatide functions as a dual GIP/GLP-1 receptor agonist, regulating insulin secretion and appetite signaling, while semaglutide operates through GLP-1 pathways to reduce hunger and slow gastric emptying. Enriquez tailors peptide selection and dosing schedules based on patient-specific factors including baseline A1C levels, body composition analysis, existing metabolic conditions, and weight loss objectives. The clinic integrates these peptide therapies within broader lifestyle modification frameworks, addressing nutrition patterns, movement habits, sleep quality, and stress management to support sustainable metabolic changes beyond pharmaceutical intervention alone.

Czarina Enriquez brings family nurse practitioner training to her Los Angeles-based practice, applying clinical expertise in endocrine function and metabolic medicine to patient assessments. Her approach involves detailed intake evaluations that examine hormonal panels, metabolic markers, and patient health histories before initiating peptide protocols. Enriquez maintains active involvement in patient care through regular follow-up consultations, dose adjustments based on response patterns and side effect profiles, and lab monitoring to track metabolic improvements. The clinic's hormone optimization services extend beyond weight management to address testosterone deficiency, thyroid dysfunction, and age-related hormonal shifts that affect energy levels, body composition, cognitive function, and overall vitality.

Patients engage with The A-List Clinic entirely through telehealth appointments, scheduling video consultations through the clinic's California-licensed platform. Initial evaluations typically include comprehensive health questionnaires, review of recent laboratory work or orders for new metabolic panels, discussion of treatment goals, and education about peptide mechanisms and expected timelines. Follow-up visits occur at intervals determined by treatment protocols—often every four weeks during titration phases—to assess weight trends, side effect management, and metabolic marker improvements. The clinic coordinates prescription fulfillment through partner pharmacies, with medications shipped directly to patient addresses throughout California, and provides detailed administration instructions for subcutaneous injection techniques.

The A-List Clinic differentiates itself through its exclusive focus on preventative metabolic medicine rather than reactive disease management, positioning interventions at stages where lifestyle and pharmaceutical tools can reverse early metabolic dysfunction. The telehealth model provides scheduling flexibility for working professionals and eliminates commute requirements while maintaining clinical rigor through structured protocols and regular provider contact. Enriquez emphasizes patient education throughout treatment, explaining the physiological mechanisms behind peptide therapies, setting realistic expectations for weight loss velocity and plateau management, and building frameworks for long-term metabolic health that extend beyond active peptide use. This educational component prepares patients to maintain results through informed lifestyle choices after completing structured peptide protocols.